Together, the data have identified a specific signature of individual RCS and their corresponding detoxifying enzyme systems, causing a specific organ pathology ranging from altered glucose metabolism, impaired glucose tolerance, loss of pancreatic insulin expression, insulin resistance to hyperglycemia. This evidence concerns the gene INS and Impaired glucose tolerance.